Does COPAXONE Cause Injection site atrophy? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Injection site atrophy have been filed in association with COPAXONE. This represents 1.0% of all adverse event reports for COPAXONE.
12
Reports of Injection site atrophy with COPAXONE
1.0%
of all COPAXONE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Injection site atrophy From COPAXONE?
Of the 12 reports.
Is Injection site atrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for COPAXONE. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does COPAXONE Cause?
Injection site pain (163)
Multiple sclerosis relapse (136)
Injection site reaction (116)
Injection site mass (69)
Injection site erythema (61)
Dyspnoea (58)
Death (50)
Drug ineffective (45)
Fatigue (42)
Pain (40)
What Other Drugs Cause Injection site atrophy?
GLATIRAMER (282)
ASFOTASE ALFA (144)
TRIAMCINOLONE ACETONIDE (121)
INTERFERON BETA-1A (103)
INTERFERON BETA-1B (44)
TRIAMCINOLONE (34)
INSULIN GLARGINE-YFGN (27)
MEDROXYPROGESTERONE (22)
INSULIN GLARGINE (17)
SOMATROPIN (17)
Which COPAXONE Alternatives Have Lower Injection site atrophy Risk?
COPAXONE vs COPEGUS
COPAXONE vs COPPER
COPAXONE vs CORDARONE
COPAXONE vs CORICIDIN HBP COLD AND FLU
COPAXONE vs CORTICOSTEROID NOS